Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 3, 2020

ViiV Healthcare gets FDA nod for HIV drug Rukobia to treat adult patients

Specialist HIV company ViiV Healthcare has secured approval from the US Food and Drug Administration (FDA) for its Rukobia (fostemsavir) 600mg extended-release tablets to treat HIV in adult patients.

ViiV Healthcare’s Rukobia product. (Credit: Business Wire)